STOCK TITAN
  1. Home
  2. Financials
  3. TARS
  4. Revenue

Tarsus Pharmaceuticals, Inc. (TARS) Revenue by Year

TARS

Tarsus Pharmaceuticals, Inc. generated $451.4M in revenue in fiscal year 2025. This represents an increase of 146.7% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $606.3M in revenue. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Tarsus Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Revenue $451.4M
YoY +146.7%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TARS Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Revenue$606.3M$451.4M+146.7%$183.0M+948.6%$17.4M-32.4%$25.8M-54.7%$57.0M$0N/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

TARS Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$173.9M+69.4%$162.1M+106.9%$151.7M+128.4%$118.7M+146.7%$102.7M+151.5%$78.3M+183.7%$66.4M$48.1M+2471.8%$40.8M$27.6M+1004.6%N/A$1.9M

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Tarsus Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Tarsus Pharmaceuticals, Inc.'s revenue in fiscal year 2025?

Tarsus Pharmaceuticals, Inc. generated $451.4M in revenue in fiscal year 2025.

How fast is Tarsus Pharmaceuticals, Inc.'s revenue growing?

Tarsus Pharmaceuticals, Inc. (TARS) revenue rose by 146.7% year over year, from $183.0M to $451.4M in fiscal year 2025.

What is Tarsus Pharmaceuticals, Inc.'s revenue over the last twelve months?

Tarsus Pharmaceuticals, Inc. (TARS) reported $606.3M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Tarsus Pharmaceuticals, Inc. (TARS) reported $173.9M in revenue in Q2 2026. This represents an increase of 69.4% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Tarsus Pharmaceuticals, Inc. (TARS) reported on that line in every period on record.